Skip to main content

Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation

An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer

A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • …
  • Next page Next
  • Last page Last
Subscribe to